BeiGene (百济神州) 9 mai 2022 China’s pharma companies are spending big on R&D, but global success remains elusive - The China Project
BeiGene (百济神州) 4 janv. 2019 Daily China: Hansoh Pharma (翰森制药) IPO: Takeaways from Recent 4+7 City Centralized Tender Results and more - Smartkarma
BeiGene (百济神州) 19 déc. 2018 Daily Healthcare: Hansoh Pharma (翰森制药) IPO: A Leading Generic Player with Regulatory Overhang (Part 1) and more - Smartkarma